Semisynthetic human insulin and highly purified porcine insulin were compared in a double blind crossover study in 21 diabetic children. Glycosylated Semisynthetic human insulin is safe and effective in diabetic children, although further work is needed to devise regimens which achieve optimal blood glucose control.
Introduction
Although human insulin differs from porcine insulin by only one amino acid situated at the C terminal of the B chain,' its potential benefits have excited great interest. Human insulin is now available for clinical use and is currently prepared by enzymatic semisynthesis from porcine insulin or by recombinant DNA techniques' using Escherichia coli.
Studies of semisynthetic human insulin show that it is safe in normal adults5 and, when using the glucose clamp technique, that its potency is indistinguishable from that of porcine insulin.6 Similar free insulin profiles have been recorded in adult diabetics after injection of porcine and human insulins. 7 We have compared semisynthetic human insulin with highly purified porcine insulin in diabetic children and have assessed clinical, metabolic, and immunological variables.
Patients and methods
Twenty one children aged 5-16 years who had had a history of diabetes for two to 12 years were recruited from a paediatric diabetic clinic. All were taking twice daily short Human or porcine soluble (Actrapid) and lente (M1onotard) insulins with a proinsulin cointent below 1 ppm were used in a strength of 40 U n,i during the study. Children were seen on a monthly basis at home but attended the outpatient clinic at each crossover point. TIhle number of hvpoglvcaemic episodes that had required treatmenit wstith extra carbohvdrate was recorded at each monthly visit. Four paltients left the study at month I I as they received inappropriate insulins thereafter. Twenty four hour urinary glucose excretion and seven point home monitored blood glucose profiles (before and after meals, and before bed) were deterrmlined at monthly intervals. Twice weekly tour point home monitored glucosc profiles were used to adjust the dose of insulin. Capillary blood was obtained from finger pricks at monthly intervals for rotal glvcosylated haemoglobin (haciooglobin Al; HbA,) estimation. In addition, at each four month visit tneasurements werc made of height and weight as well as C peptide, insulin antibody, and hlaemoglobin concentrations, total white cell count, erTthrocvte sedimentation rate, urea and electrolyte concotntrations, liver function valtues, and cholesterol and triglyceride concen [Lations.
Lab&rator-A miethods-HbA, was measured by an electroendosmosis m-nethod Corning M1edical and Scientific) sith an interbatch coefficient of variation of 6 6.,, (mean HbA, 13",,) . Serum C peptide concentration xvas measured bxt radioimmunoassay. Insulin antibody concentrations were measured immunocheinically by a second antibody coprecboitation assay.'" IgG antibodv reactive with both "I labelled porcine and human insulins was mreasured in each sample. HbA, values at the end of treatment periods were higher after the use of human insulin (A7 with B 11; fig 1) than after the use of porcine insulin (B7 with A1l)-15 7",, (2 3",,) v 14 2",, (2 3'",); p<0 01. Mean HbA, values were also higher when the patients were treated with human insulin compared with porcine insulin during months 7-15 (table II) . 26 NOVEMBER 1983 greater disparity in the binding of human versus porcine insulin occurred at the end of eaclh treatment period with human insulin in contrast to the levels observed at the end of treatment periods with porcine insulin. There was a reduction in the levels of binding to human insulin during treatment with porcine insulin (A7 v All, and Bl I v B15)-7 6 (4-7) v 6 1 (3-5) 'ig 1 (p<0 05), and 6-7 (4 1) v 4-4 (2 1) ig l (p < 005), respectively. Measu-rements of full blood count, liver function values, and urea, electrol-tc, cholesterol, and triglyceride concentrations remained unchanged and within normal limits throughout.
Discussion
It is notoriously difficult to achieve adequate blood glucose control in diabetic children.2 Since they are at high risk of microvascular disease" and have decades of treatment ahead of them, the potential benefits of a new treatment need to be assessed critically. The immunological responsiveness of children to insulin may differ from that of adults, further strengthening the case for a separate study." '" Our study was designed so that each child had twvo crossovers of insulin species prepared in highly purified soluble and lente forms.
Most of the children participating in this studv had poor diabetic control as judged by HbA, values, but these tended to be higihcr during treatment with human compared wvith porcine insulin. Fasting hlood glucose concentrations were higher with human insulin and similar results have been observed in patients treated with biosynthetic human insulin.' This may be due to a differen-ce in the pharmacokinetics of these twTo insulins, with a slightly accelerated absorption of human compared with porcine insulin, possibly associated with a shorter duration of action.' Other studies using the glucose clamp technique or glucose controlled inftusion system (aitificial pancreas), however, have failed to detect these small differences.' I" During this study no attempt was made to alter the ratio of short to intermediate acting insulin, which remained constant throughout.
Concentrations of insulin antibody reactive with both human and porcine insulin were measured at each change of insulin species. Comparable levels of binding are usually found for both these ligands in patients treated wTith bovine, porcine, or human insulins." In our study these levels were broadly similar, although patients in both groups showed a mild preference for binding to human insulin; this difference was present in group A on entry to the study (fig 3) . This preferential binding may be related to previous exposure to a variety of bovine and porcine insulin preparations.
Insulin antibody reactive with both species of labelled insulin showed an overall fall throughout the study and, although group A started out with higher binding levels, the levels were comparable for both groups at the end of the study, both groups showing comparable binding for the two ligands. A greater degree of binding of human versus porcine insulin was evident at the end of each human insulin treatment period compared with the levels observed at the end of each porcine insulin treatment period. A larger study in adults using a similar protocol has not shown such differences in insulin antibody production during porcine and human insulin treatment (P D Home, N P Mann, A S Hutchinson, et al, submitted for publication), but possibly children may respond more vigorously to minor changes in insulin chemistry or formulation. It is unlikely, however, that the changes observed in the present study are of clinical significance. A study in newly diagnosed diabetics suggested that there is less antibody production to human insulin compared with porcine insulin.'!) Administration of homologous-that is, prepared from the same species-insulin has been shown to induce antibodies in man as well as other animals20 and, although the mechanism is not fully understood, probably it includes some form of physicochemical change occurring either before or after injection.2'
The human and porcine insulin preparations used were effectively free of proinsulin and had a desamido insulin content of <0 20, at the time of manufacture (J Brange, unpublished observations, 1983 
